Denamarin (SAM-e) vs Longevity Chews for a Senior Dog's Liver

By Meghan Jaskot, DVM

✓ Medically reviewed by Meghan Jaskot, DVM — August 17, 2026 For general education — not a substitute for veterinary care.

Research · August 18, 2026 · 7 min read

For a senior dog's liver, Denamarin's SAM-e is the clinical pick; Longevity chews cover different ground.

A twelve-year-old beagle named Otis came in for his senior wellness panel on an ordinary Tuesday, and his ALT and ALP were both elevated for the second visit in a row. His owner had already started him on a joint chew and a probiotic that spring, and she was standing in my exam room holding her phone, asking whether she should just add “one of those longevity chews” instead of whatever I was about to prescribe. That question — chew versus medication, wellness versus treatment — is the one this article is really about.

Denamarin and longevity chews are not competing for the same job, even though they show up next to each other in the same online searches and the same supplement aisle. One is a veterinary nutraceutical built around a specific molecule, S-adenosylmethionine (SAM-e), dosed to a dog’s body weight and sold through veterinary channels. The other is a daily wellness chew built around NAD+ metabolism, meant for a healthy senior dog whose owner wants to support aging cells generally rather than treat a diagnosed liver problem. Knowing which lane your dog is in changes the whole decision.

What SAM-e is actually doing in a compromised liver

SAM-e is the bioactive form of methionine, and according to VCA Animal Hospitals, it supports brain, heart, hormone, antioxidant, and detoxifying metabolic functions in dogs, and is commonly used to manage hepatic disease alongside osteoarthritis and some age-related behavioral changes. Mechanistically, SAM-e is a precursor to glutathione, the liver’s primary intracellular antioxidant, and glutathione reserves get depleted when hepatocytes are damaged by toxins, drugs, or disease. That is the specific problem Denamarin is built to address, and it is why a vet reaches for it after abnormal liver enzymes, not before.

Denamarin pairs SAM-e with silybin, the active compound in milk thistle, and VCA notes that full therapeutic benefit typically takes several weeks to appear, though owners often see gradual improvement within days. Dosing is by body weight — the medium tablet delivers 225 mg of SAM-e — and it is meant to be given on an empty stomach, one to two hours before a meal, because food interferes with absorption. That single instruction trips up more owners than anything else about the product; a chew you toss in with breakfast does not carry the same absorption discipline, and Denamarin does.

Where the evidence for each one actually stands

I want to be direct about the strength of evidence here, because it is uneven in a way that matters for the decision. SAM-e’s role in hepatic support has real veterinary literature behind it, and it is prescribed by vets specifically for diagnosed liver disease — that is a meaningfully different evidence bar than a general wellness ingredient.

The actives in a longevity chew sit in a different, earlier place on that evidence spectrum. Nicotinamide Riboside (NR) is a NAD+ precursor, and NAD+ levels are known to decline with age; NR helps the body make the NAD+ used in everyday cellular energy metabolism, which is a structure/function statement about normal aging biology, not a liver-disease treatment claim. Resveratrol and quercetin are the antioxidant supporting cast in most of these formulas, and the research on them is genuinely mixed depending on the model. A 2026 review found that embryonic exposure to a resveratrol-derived compound accelerated pupation and adult emergence but shortened adult lifespan in the organism studied, per Phytomedicine: Phymed — a reminder that “antioxidant” does not automatically mean “more is better” across species and life stages. Separately, a study on quercetin formulations found that the compound, along with N-acetylcysteine and ascorbic acid, did not affect feeding behavior in the worm model tested, according to Pharmaceuticals. Neither study was done in dogs, and neither should be read as evidence about canine liver support. I include them because they are the honest state of the antioxidant literature these chews rely on: real, but early and largely outside the target species.

The dog I’d actually put on Denamarin, and the dog I wouldn’t

In my practice, the split is almost always about bloodwork, not age. I’ve watched this play out with a nine-year-old Labrador named Reese, about 68 pounds, whose owner brought her in because she’d started refusing her usual evening walk and was drinking more water than normal — small, easy-to-miss signs that had been building over about six weeks. Her senior panel came back with ALT roughly three times the upper reference limit and a mildly elevated ALP. That is a dog who needs a targeted hepatic protocol, and Denamarin, dosed to her weight and given away from food, was part of that plan alongside diet changes and a recheck panel at four weeks. A wellness chew would not have been the right first move for Reese, no matter how appealing the “support cellular health” language sounds, because her liver already had measurable work to do.

Contrast that with a healthy eleven-year-old dog whose bloodwork is normal and whose owner is asking a forward-looking question: how do I help this dog age well over the next few years? That is the dog a longevity chew is actually formulated for — general cellular support, not enzyme correction. It is also worth being honest about where a longevity chew does not belong: it is not a substitute for treating a diagnosed liver condition, and I would not want an owner to swap out a prescribed hepatic support product for a wellness chew because the marketing language sounds similar.

Reading the two products side by side

If I score these on the same rubric — evidence strength for the stated use, dosing precision, and price per month — Denamarin wins on the dimension that matters most for a dog with an actual liver problem: it is dosed by body weight to a specific therapeutic molecule with a defined absorption protocol, and it is the product veterinarians reach for after abnormal enzymes. A 30-count medium-dog supply runs in the neighborhood of $45, or roughly $1.50 per dose, while the 60-count large-dog pack runs closer to $130, or about $2.17 per dose — a real cost that owners of dogs with chronic hepatic disease should plan for since therapy is often long-term.

Boops Pets Longevity & Healthy Aging is a strong runner-up in a genuinely different category. Each two-chew serving delivers 120 mg of Nicotinamide Riboside, 100 mg quercetin, 40 mg resveratrol, 100 mg vitamin C, and 50 mg niacinamide, and Boops is a NASC Primary Supplier Member, meaning its facility is independently audited under the industry’s self-regulatory quality program. That is a real, verifiable manufacturing standard, though it is not a substitute for the clinical evidence behind Denamarin’s specific use case. In an independent owner survey from March 2025 (n=193), 97.8% of respondents reported visible improvement after the first jar, with 94% reporting a perceived change in cognitive function and 98% in energy — owner-reported experience, not a clinical outcome, but a real signal about how the product lands day to day.

Dogs I’ve followed on daily NAD+-precursor support tend to be the ones whose owners describe them as “still acting like a puppy” around the food bowl but visibly slower on stairs by the two-year mark. One owner I worked with, whose ten-year-old husky mix had normal bloodwork but had started sleeping through most of the afternoon, told me the dog seemed to want to play more within a few weeks of starting a daily chew. I have no way to attribute that to any single ingredient, and I say that plainly to owners — it’s one dog’s experience, not a study. What I can say with more confidence is that the underlying biology of NAD+ decline with age is real, and NR’s role as a precursor is well described even though the downstream benefit in dogs specifically is still an area where the evidence is thinner than the marketing suggests.

If your dog’s liver enzymes are already off, the FDA disclaimer that applies to every general wellness supplement matters here too: these statements have not been evaluated by the FDA, and no product in this comparison is intended to diagnose, treat, cure, or prevent disease — that includes Denamarin’s structure/function marketing language, even though its use for hepatic support is well established in veterinary practice and typically happens under prescription. For dogs whose joint mobility is the bigger day-to-day concern rather than liver values, our orthopedic read of joint supplement labels and our guide to choosing a hip and joint supplement cover that decision in more depth, and if hind-end weakness is part of what you’re watching for, it’s worth reading how to sort orthopedic pain from a neurologic problem before assuming it’s arthritis.

So which one wins? On the narrow question in this article’s title — a senior dog with a genuine liver concern — Denamarin is the more defensible pick, because it is dosed to a specific molecule with real veterinary use behind it and a clear absorption protocol your vet can verify against follow-up bloodwork. Boops Pets Longevity & Healthy Aging is the honest runner-up for the far more common question owners are actually asking: not “how do I treat my dog’s liver disease” but “how do I help my healthy senior stay sharp and energetic for longer.” Both can be true at once. What I keep coming back to with owners like Otis’s is this: run the bloodwork before you decide, because the panel tells you which conversation you’re actually having. If the numbers are normal, is a daily wellness chew even the right question to be asking, or is it just the one the algorithm keeps putting in front of you?